The 1962 hit song is being turned into an animated movie at Miramax. Jury awards $10 million to teacher who was shot by 6-year-old student Kansas mayor hit with criminal charges for allegedly voting ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

The Philadelphia Phillies secured a first-round bye in the playoffs with a historic win over the Miami Marlins on Wednesday, smashing a franchise-record eight home runs in a single game, with five ...

Hall of Fame quarterback Dan Marino recently revealed that he was diagnosed with metabolic dysfunction-associated steatohepatitis, or MASH. The Miami Dolphins legend said the discovery came years ago ...

Marine veteran Monty Dahm has long wanted to build a replica of Tun Tavern, the legendary birthplace of the U.S. Marine Corps, near its original site in Philadelphia. Earlier this month, he reached an ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...

In adults with metabolic dysfunction-associated steatohepatitis (MASH), 20 weeks of moderate-intensity aerobic exercise led to disease resolution more than twice as often as standard care, as well as ...

A Marine veteran hopes to convert an existing restaurant into a replica of the Tun Tavern in Philadelphia. Here, a U.S. Marine, representing a Marine from WWII, walks out the doors of a Tun Tavern ...

"We show that this design can, in principle, find half of all existing Earth-like planets orbiting sun-like stars within 30 light-years in less than three years." To resolve nearby Earth-like ...

Concept design for a rectangular space telescope, modeled after the Diffractive Interfero Coronagraph Exoplanet Resolver (DICER), a notional infrared space observatory, and the James Webb Space ...

Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an ...